HD
43
8
DGX
28
4
PWR
63
3
JCI
44
7
BEN
36
4
FSLR
50
6
CTAS
36
8
RRC
52
2
F
38
4
AEE
51
3
FIS
43
5
ZBH
69
15
ORCL
49
3
CAH
44
7
GE
60
5
DTE
49
16
UHS
50
4
KLAC
45
3
NEM
30
2
EOG
28
2
HD
43
8
DGX
28
4
PWR
63
3
JCI
44
7
BEN
36
4
FSLR
50
6
CTAS
36
8
RRC
52
2
F
38
4
AEE
51
3
FIS
43
5
ZBH
69
15
ORCL
49
3
CAH
44
7
GE
60
5
DTE
49
16
UHS
50
4
KLAC
45
3
NEM
30
2
EOG
28
2
Financhill
Back

Crinetics Pharmaceuticals 10K Form

Sell
28

CRNX
Crinetics Pharmaceuticals

Last Price:
$53.63
Seasonality Move:
-9.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRNX News And Ratings

See the #1 stock for the next 7 days that we like better than CRNX

CRNX Financial Statistics

Sales & Book Value

Annual Sales: $4M
Cash Flow: $-63.4M
Price / Cash Flow: 0
Annual Sales: $10.30
Price / Book: 5.96

Profitability

EPS (TTM): -3.73000
Net Income (TTM): $-277.9M
Gross Margin: --
Return on Equity: -42.43%
Return on Assets: -37.11%

Crinetics Pharmaceuticals Earnings Forecast

Key Crinetics Pharmaceuticals Financial Ratios

  • The Research & Development expenses have been 4,199.53% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CRNX is -5,345.85% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Crinetics Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRNX
CUSIP: 22663K
Website: crinetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 16.09
Quick Ratio: 15.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRNX Technical Analysis vs Fundamental Analysis

Sell
28
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy or a Sell?